HealthScout Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 
 
 Printer Friendly  Send to a Friend

Magnesium Sulfate Reduces Threat of Cerebral Palsy

Compound given to women at risk of preterm birth cuts risk in half, study finds

By Kathleen Doheny
HealthDay Reporter


Related Encyclopedia
 border=
Acoustic Neurinoma
AIDS and HIV Infection
Amenorrhea
Amniocentesis
More...

Related Healthscout Videos
 border=
A Welcome Message from Survivor PJ Hamel
Smother Says "Cut!"
Maryann and Paula
When's the Next Free Mammogram Day? October 17, 2008!!!
More...

Related Animations
 border=
Breast Reduction
Breast Self-Exam Video
Erectile Dysfunction
Facelift
More...

Related Drug Information
 border=
Actonel
Adderal XR
Cialis
Concerta
More...

Related News Articles
 border=
Family History of Aneurysm Raises Stroke Risk for Smokers
Heart Drug May Be a Cancer Fighter
More 'Screen Time' Linked to Poor Fitness in Girls
Study of Everest Climbers Questions Oxygen Use
More...

WEDNESDAY, Aug. 27 (HealthDay News) -- Magnesium sulfate, given to mothers at risk of preterm delivery, cut the rate of cerebral palsy in their babies by nearly half, a new study found.

"If deemed to be at high or immediate risk of delivery prior to 32 weeks, women and their doctors should consider using magnesium sulfate to prevent their child from having cerebral palsy," said study lead author Dr. Dwight J. Rouse, a professor of obstetrics and gynecology at the University of Alabama at Birmingham.

Text Continues Below



The findings are published in the Aug. 28 issue of the New England Journal of Medicine.

But in an editorial accompanying the study, other experts called for caution and more study before routinely recommending the treatment to prevent cerebral palsy.

In the study, the largest of its kind, Rouse and his colleagues randomly assigned 2,241 women at risk of delivering early -- between 24 and 31 weeks -- to receive either magnesium sulfate or a placebo. (Babies born after 37 to 42 weeks of pregnancy are considered full term, according to the March of Dimes.) The magnesium sulfate was given intravenously as the women entered labor as a 6-gram dose followed by a constant infusion of 2 grams per hour until either 12 hours had passed, labor had subsided, or they had given birth.

The researchers then compared infants born to each group of mothers to see if there were differences in the rates of death or the occurrence of cerebral palsy.

Cerebral palsy, marked by abnormal movement control and postures that cause limited activity, is caused by damage or dysfunction to the developing fetal or infant brain. Preterm birth is itself a risk factor for the condition. About one third of cerebral palsy cases are associated with preterm birth.

In past studies, magnesium sulfate hasn't borne out as an effective treatment for delay of early labor. But it has proven effective for treatment of maternal high blood pressure associated with pregnancy, Rouse said.

Page:  1 | 2 | Next >>

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 8/27/2008

Related Links
 border=
From Healthscout's partner site on chronic pain, ChronicPainConnection.com
Find ways to get chronic pain relief!
Find a right treatment for your chronic pain
Join our community - your chronic pain support group.




SOURCES: Dwight J. Rouse, M.D., professor of obstetrics and gynecology, University of Alabama at Birmingham; William Zinser, M.D., pediatric neurologist, Children's Medical Center, Dallas, and associate professor of pediatric neurology, University of Texas Southwestern Medical Center at Dallas; Aug. 28, 2008, New England Journal of Medicine


Healthscout Search
Health Tools
 Neurology Health Center
 Understanding Multiple Sclerosis
 Fibromyalgia Basics
 Video: Alzheimer's Disease
 Migraine - What is it?
Resources
Healthscout News
Health Videos
Quizzes & Tools
Health Encyclopedia
Library & Communities
Newsletter Subscription
News Archive
PR Newswire News Video Releases
Privacy Policy

We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service